Curanex Pharmaceuticals Inc CURX
4.74
0.29
6.52%
as of 25 Sep
- Market cap
- $7.0M
- P/E
- 0.0×
Follow CURX
| Dec '24 | Dec '25 | |
|---|---|---|
Current Ratio |
35.47 | 81.95 |
Net Debt/EBITDA |
0.41 | 1.20 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
— | 0.00 |
Operating CF/Net income |
1.54 | 2.48 |
Capex/Depreciation |
— | 0.00 |
Interest Coverage |
0.00 | 0.00 |
| 0.00% | (72.09%) | |
| 0.00% | (69.85%) | |
ROIC |
(64.37%) | (42.42%) |
Return on Tangible Assets |
(71.83%) | (38.10%) |
Research and Development Expense of Revenue |
— | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.84) | (8.22) |
Cash per Share |
0.22 | 3.90 |
Shareholders Equity per Share |
0.76 | 8.80 |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
0.76 | 8.80 |
Free Cash Flow |
(0.56) | (10.48) |
Working Capital |
0.50 | 11.09 |
Net Current Asset Value |
0.50 | 10.87 |
| Other line items | ||
Quick Ratio |
10.20 | 36.30 |
Depreciation/Fixed assets |
— | 0.00 |
Cash ROIC |
(85.18%) | (64.75%) |
Accounts Payable Turnover |
— | 0.00 |
Average Days of Payables |
0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(0.84) | (8.22) |
Capex per Share |
0.00 | 0.00 |
Average Payables |
— | 0.00 |
Average Assets |
— | 6.05 |
Average Common Equity |
— | 5.86 |
Net Profit Margin |
0.00% | 0.00% |
Columns are period end dates